Cancer Biomarkers Market
Cancer Biomarkers Market Analysis by Test Type (PSA Tests CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, KRAS Mutation Tests), by Illness Indication (Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer), by Region - Global Insights 2022-2032
Analysis of Cancer Biomarkers market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 2. Research Methodology & Assumptions 3. Executive Summary 4. Global Cancer Biomarkers Products Market Overview 4.1. Introduction (Product Definition) 4.2. Industry Evolution/Development 4.3. Key Market Indicators 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Opportunity 4.5. Global Cancer Biomarkers Market Analysis and Forecasts, 2022-2032 4.6. Cancer Biomarkers Market - Global Supply Demand Scenario 4.7. Porter’s Five Force Analysis 4.8. Market Outlook 4.9. Cancer Epidemiology, by region 5. Global Cancer Biomarkers Market Analysis and Forecast by Test Type 5.1. Key Findings 5.2. Introduction 5.3. Market Size (US$ Mn) Forecast, By Test Type 5.3.1. PSA Tests 5.3.2. CTC Tests 5.3.3. AFP Tests 5.3.4. CA Tests 5.3.5. HER2 Tests 5.3.6. BRCA Tests 5.3.7. ALK Tests 5.3.8. CEA Tests 5.3.9. EGFR Mutation Tests 5.3.10. KRAS Mutation Tests 5.3.11. Others 5.4. Market Attractiveness, By Test Type 5.5. Key Trends 6. Global Cancer Biomarkers Market Analysis and Forecast by Disease Indication 6.1. Key Findings 6.2. Introduction 6.3. Market Size (US$ Mn) Forecast, By Disease Indication 6.3.1. Breast Cancer 6.3.2. Lung Cancer 6.3.3. Colorectal Cancer 6.3.4. Melanoma 6.3.5. Blood Cancer 6.3.6. Prostate Cancer 6.3.7. Ovarian Cancer 6.3.8. Stomach Cancer 6.3.9. Liver Cancer 6.3.10. Others 6.4. Market Attractiveness, By Disease Indication 6.5. Key Trends 7. Global Cancer Biomarkers Market Analysis and Forecast by Region 7.1. Key Findings 7.2. Introduction 7.2.1. Market Size (US$ Mn) Forecast, By Region 7.2.2. North America 7.2.3. Europe 7.2.4. Asia Pacific 7.2.5. Latin America 7.2.6. Middle East and Africa 8. North America Cancer Biomarkers Market Analysis and Forecast by Region 8.1. Key Findings 8.2. North America Cancer Biomarkers Market Forecast, by Test Type 8.3. North America Cancer Biomarkers Market Forecast, by Disease Indication 8.4. North America Cancer Biomarkers Market Forecast, by Country 8.4.1. U.S. Cancer Biomarkers Market Overview 8.4.2. Canada Cancer Biomarkers Market Overview 8.5. North America Market Attractiveness Analysis 8.6. Market Trends 9. Europe Cancer Biomarkers Market Analysis and Forecast by Region 9.1. Key Findings 9.2. Europe Cancer Biomarkers Market Forecast, by Test Type 9.3. Europe Cancer Biomarkers Market Forecast, by Disease Indication 9.4. Europe Cancer Biomarkers Market Forecast, by Country 9.4.1. U.K. Cancer Biomarkers Market Overview 9.4.2. Germany Cancer Biomarkers Market Overview 9.4.3. France Cancer Biomarkers Market Overview 9.4.4. Italy Cancer Biomarkers Market Overview 9.4.5. Spain Cancer Biomarkers Market Overview 9.4.6. Russia Cancer Biomarkers Market Overview 9.4.7. Rest of Europe Cancer Biomarkers Market Overview 9.5. Europe Market Attractiveness Analysis 9.6. Market Trends 10. Asia Pacific Cancer Biomarkers Market Analysis and Forecast by Region 10.1. Key Findings 10.2. Asia Pacific Cancer Biomarkers Market Forecast, by Test Type 10.3. Asia Pacific Cancer Biomarkers Market Forecast, by Disease Indication 10.4. Asia Pacific Cancer Biomarkers Market Forecast, by Country 10.4.1. India Cancer Biomarkers Market Overview 10.4.2. China Cancer Biomarkers Market Overview 10.4.3. Japan Cancer Biomarkers Market Overview 10.4.4. Australia & New Zealand Cancer Biomarkers Market Overview 10.4.5. Rest of APAC Cancer Biomarkers Market Overview 10.5. Asia Pacific Market Attractiveness Analysis 10.6. Market Trends 11. Latin America Cancer Biomarkers Market Analysis and Forecast by Region 11.1. Key Findings 11.2. Latin America Cancer Biomarkers Market Forecast, by Test Type 11.3. Latin America Cancer Biomarkers Market Forecast, by Disease Indication 11.4. Latin America Cancer Biomarkers Market Forecast, by Country 11.4.1. Brazil Cancer Biomarkers Market Overview 11.4.2. Mexico Cancer Biomarkers Market Overview 11.4.3. Rest of LATAM Cancer Biomarkers Market Overview 11.5. Latin America Market Attractiveness Analysis 11.6. Market Trends 12. Middle East and Africa Cancer Biomarkers Market Analysis and Forecast by Region 12.1. Key Findings 12.2. Middle East and Africa Cancer Biomarkers Market Forecast, by Test Type 12.3. Middle East and Africa Cancer Biomarkers Market Forecast, by Disease Indication 12.4. Middle East and Africa Cancer Biomarkers Market Forecast, by Country 12.4.1. South Africa Cancer Biomarkers Market Overview 12.4.2. GCC countries Cancer Biomarkers Market Overview 12.4.3. Rest of MEA Cancer Biomarkers Market Overview 12.5. Middle East and Africa Market Attractiveness Analysis 12.6. Market Trends 13. Competitive Landscape 13.1. Market Share Analysis, by Company 13.2. Competition Matrix 13.3. Company Profiles 13.3.1. Abbott Laboratories 13.3.1.1. Company Details 13.3.1.2. Business Overview 13.3.1.3. Financial Overview 13.3.1.4. Strategic Overview 13.3.1.5. SWOT Analysis 13.3.2. Merck & Co., Inc. 13.3.2.1. Company Details 13.3.2.2. Business Overview 13.3.2.3. Financial Overview 13.3.2.4. Strategic Overview 13.3.2.5. SWOT Analysis 13.3.3. Thermo Fisher Scientific Inc. 13.3.3.1. Company Details 13.3.3.2. Business Overview 13.3.3.3. Financial Overview 13.3.3.4. Strategic Overview 13.3.3.5. SWOT Analysis 13.3.4. Illumina, Inc. 13.3.4.1. Company Details 13.3.4.2. Business Overview 13.3.4.3. Financial Overview 13.3.4.4. Strategic Overview 13.3.4.5. SWOT Analysis 13.3.5. bioMérieux SA 13.3.5.1. Company Details 13.3.5.2. Business Overview 13.3.5.3. Financial Overview 13.3.5.4. Strategic Overview 13.3.5.5. SWOT Analysis 13.3.6. QIAGEN 13.3.6.1. Company Details 13.3.6.2. Business Overview 13.3.6.3. Financial Overview 13.3.6.4. Strategic Overview 13.3.6.5. SWOT Analysis 13.3.7. Agilent Technologies, Inc. 13.3.7.1. Company Details 13.3.7.2. Business Overview 13.3.7.3. Financial Overview 13.3.7.4. Strategic Overview 13.3.7.5. SWOT Analysis 13.3.8. Hologic, Inc. 13.3.8.1. Company Details 13.3.8.2. Business Overview 13.3.8.3. Financial Overview 13.3.8.4. Strategic Overview 13.3.8.5. SWOT Analysis 13.3.9. Novartis AG 13.3.9.1. Company Details 13.3.9.2. Business Overview 13.3.9.3. Financial Overview 13.3.9.4. Strategic Overview 13.3.9.5. SWOT Analysis 13.3.10. F. Hoffmann-La Roche Ltd. 13.3.10.1. Company Details 13.3.10.2. Business Overview 13.3.10.3. Financial Overview 13.3.10.4. Strategic Overview 13.3.10.5. SWOT Analysis 13.3.11. Genomic Health, Inc. 13.3.11.1. Company Details 13.3.11.2. Business Overview 13.3.11.3. Financial Overview 13.3.11.4. Strategic Overview 13.3.11.5. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 02: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 03: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Region Type, 2015-2032
Table 04: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 05: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 06: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032
Table 07: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 08: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 09: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032
Table 10: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 11: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 12: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032
Table 13: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 14: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 15: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032
Table 16: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015-2032
Table 17: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015-2032
Table 18: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 02: Global Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 03: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PSA Tests, 2022-2032
Figure 04: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CTC Tests, 2022-2032
Figure 05: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by AFP Tests, 2022-2032
Figure 06: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CA Tests, 2022-2032
Figure 07: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by HER2 Tests, 2022-2032
Figure 08: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by BRCA Tests, 2022-2032
Figure 09: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ALK Tests, 2022-2032
Figure 10: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CEA Tests, 2022-2032
Figure 11: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EGFR Tests, 2022-2032
Figure 12: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by KRAS Mutation Tests, 2022-2032
Figure 13: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022-2032
Figure 14: Cancer Biomarkers Market Attractiveness Analysis by Test Type
Figure 15: Global Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 16: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2022-2032
Figure 17: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2022-2032
Figure 18: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2022-2032
Figure 19: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melanoma, 2022-2032
Figure 20: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Cancer, 2022-2032
Figure 21: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2022-2032
Figure 22: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ovarian Cancer, 2022-2032
Figure 23: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stomach Cancer, 2022-2032
Figure 24: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liver Cancer, 2022-2032
Figure 25: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022-2032
Figure 26: Cancer Biomarkers Market Attractiveness Analysis by Disease Indication
Figure 27: Global Cancer Biomarkers Market Value Share Analysis by Region Type, 2022 and 2032
Figure 28: Cancer Biomarkers Market Attractiveness Analysis, By Region Type
Figure 29: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 30: North America Market Attractiveness Analysis by Country
Figure 31: North America Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 32: North America Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 33: North America Market Value Share Analysis by Country, 2022 and 2032
Figure 34: North America Market Attractiveness Analysis, By Test Type
Figure 35: North America Market Attractiveness Analysis, By Disease Indication
Figure 36: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 37: Europe Market Attractiveness Analysis by Country
Figure 38: Europe Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 39: Europe Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 40: Europe Market Value Share Analysis by Country, 2022 and 2032
Figure 41: Europe Market Attractiveness Analysis, By Test Type
Figure 42: Europe Market Attractiveness Analysis, By Disease Indication
Figure 43: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 44: Asia Pacific Market Attractiveness Analysis by Country
Figure 45: Asia Pacific Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 46: Asia Pacific Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 47: Europe Market Value Share Analysis by Country, 2022 and 2032
Figure 48: Asia Pacific Market Attractiveness Analysis, By Test Type
Figure 49: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 50: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 51: Latin America Market Attractiveness Analysis by Country
Figure 52: Latin America Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 53: Latin America Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 54: Latin America Market Value Share Analysis by Country, 2022 and 2032
Figure 55: Latin America Market Attractiveness Analysis, By Test Type
Figure 56: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 57: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, 2022-2032
Figure 58: Middle East & Africa Market Attractiveness Analysis by Country
Figure 59: Middle East & Africa Cancer Biomarkers Market Value Share Analysis by Test Type, 2022 and 2032
Figure 60: Middle East & Africa Cancer Biomarkers Market Value Share Analysis by Disease Indication, 2022 and 2032
Figure 61: Middle East & Africa Market Value Share Analysis by Country, 2022 and 2032
Figure 62: Middle East & Africa Market Attractiveness Analysis, By Test Type
Figure 63: Middle East & Africa Market Attractiveness Analysis, By Disease Indication
Figure 64: Global Cancer Biomarkers Market Share Analysis by Company (2022)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Cancer Biomarkers Market
*Mail attachment includes 64 figures & 18 tables